JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B8016 UNC2025
1 Citation

Target: MER|FLT3

Summary: orally bioavailable dual MER/FLT3 inhibitor

≥23.85 mg/mL
B7785 LDN 209929 dihydrochloride

Target: haspin kinase

Summary: haspin kinase inhibitor

<40.58 mg/mL
B4797 HSP990 (NVP-HSP990)

Target: HSP90

Summary: Hsp90 inhibitor, potent and selective

insoluble in H2O; insoluble in EtOH; ≥12.3 mg/mL
B4882 PF-06463922

Target: ALK|ROS1

Summary: ALK/ROS1 inhibitor,potent and selective

insoluble in H2O; ≥20.3 mg/mL
B4886 DTP3 TFA

Summary: inhibitor of GADD45β/MKK7 complex

≥52.7 mg/mL
B4916 GSK 5959

Summary: BRPF1 bromodomain inhibitor

≥39.4 mg/mL
B5822 TMC647055 Choline salt

Summary: inhibitor of the hepatitis C virus NS5B polymerase

insoluble in H2O; insoluble in EtOH; ≥72.8 mg/mL
B5839 SU6656
2 Citation

Target: Src|Lyn|YES|Fyn

Summary: Src tyrosine kinases inhibitor

insoluble in H2O; insoluble in EtOH; ≥18.55 mg/mL
A1043 Angiotensin III (human, mouse)

Summary: Aldosterone stimulator

≥23.2 mg/mL
B7811 CPI-455 HCl

Summary: KDM5 inhibitor

≥31.5 mg/mL